Ad is loading...
JSMGX vs VEXRX
JSMGX vs VEXRX Comparison
Open Charts JSMGX vs VEXRX
Janus Henderson Triton I
Price$24.84
Change+$0.55 (+2.26%)
VolumeN/A
Net Assets5.55B
JSMGX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
JSMGX vs. VEXRX commentary
Apr 25, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSMGX is a Buy and VEXRX is a Buy.
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. JSMGX (5.55B). VEXRX pays higher dividends than JSMGX: VEXRX (0.56) vs JSMGX (0.00). JSMGX was incepted earlier than VEXRX: JSMGX (16 years) vs VEXRX (23 years). JSMGX (0.77) is less costly to investors than VEXRX (0.34). VEXRX is a more actively managed with annual turnover of: 35.00 vs. JSMGX (19.00). VEXRX has a lower initial minimum investment than JSMGX: VEXRX (50000) vs JSMGX (1000000). JSMGX annual gain was more profitable for investors over the last year : -8.31 vs. VEXRX (-12.82). VEXRX return over 5 years is better than : 15.80 vs. JSMGX (-3.23).
| JSMGX | VEXRX | JSMGX / VEXRX | |
| Total Expense Ratio | 0.77 | 0.34 | 226% |
| Annual Report Gross Expense Ratio | 0.77 | 0.34 | 226% |
| Fund Existence | 16 years | 23 years | - |
| Gain YTD | -10.369 | -14.722 | 70% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 50000 | 2,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.55B | 19.8B | 28% |
| Annual Yield % from dividends | 0.00 | 0.56 | - |
| Returns for 1 year | -8.31 | -12.82 | 65% |
| Returns for 3 years | -18.41 | -9.40 | 196% |
| Returns for 5 years | -3.23 | 15.80 | -20% |
| Returns for 10 years | -3.69 | -1.76 | 209% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XBI | 79.10 | 1.46 | +1.88% |
| SPDR® S&P Biotech ETF | |||
| CHI | 9.78 | 0.17 | +1.77% |
| Calamos Convertible Opportunities and Income Fund | |||
| SBIO | 28.02 | 0.45 | +1.63% |
| ALPS Medical Breakthroughs ETF | |||
| BCDF | 28.54 | 0.12 | +0.44% |
| Horizon Kinetics Blockchain Dev ETF | |||
| FEP | 41.67 | -0.06 | -0.14% |
| First Trust Europe AlphaDEX® ETF | |||